Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
27.90
0.00 (0.00%)
May 14, 2025, 9:30 AM - Market open
Azenta Revenue
Azenta had revenue of $143.42M in the quarter ending March 31, 2025, with 5.18% growth. This brings the company's revenue in the last twelve months to $669.17M, up 8.56% year-over-year. In the fiscal year ending September 30, 2024, Azenta had annual revenue of $656.32M, down -1.32%.
Revenue (ttm)
$669.17M
Revenue Growth
+8.56%
P/S Ratio
2.00
Revenue / Employee
$202,779
Employees
3,300
Market Cap
1.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 656.32M | -8.75M | -1.32% |
| Sep 30, 2023 | 665.07M | 109.57M | 19.73% |
| Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
| Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
| Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
AZTA News
- 17 hours ago - Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - PRNewsWire
- 6 days ago - Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 - PRNewsWire
- 19 days ago - Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast - PRNewsWire
- 7 weeks ago - Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report - PRNewsWire
- 2 months ago - Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum - PRNewsWire
- 3 months ago - Azenta, Inc. (AZTA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 - PRNewsWire